102.645 articles found

Impact of expiratory muscle strength training on swallowing function in Parkinson's disease: insights from high-resolution videomanometry.

de Oliveira Rocha FC, Dias Marques CH, Oliveira Lemme EM, Abrahão-Júnior LJ.

Clinics (Sao Paulo) · 2026-09-26

DOI: 10.1016/j.clinsp.2026.101167PMID: 42800081

Correction: Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease.

Gaetani L, Bellomo G, Chiasserini D, De Rocker C, Goossens J, Paoletti FP, Vanmechelen E, Parnetti L.

Alzheimers Res Ther · 2026-09-26

DOI: 10.1186/s13195-026-02197-zPMID: 42800866

CRISPR-dCas13a-based electrochemical biosensor for sensitive detection of miR-331-5p as a potential biomarker of Parkinson's disease.

Yiğit İ, Azrak B, Uygun ZO.

Anal Biochem · 2026-09-26

DOI: 10.1016/j.ab.2026.116260PMID: 42800399

Systemic energy and neuroinflammatory disturbances in a lactacystin-induced rat model of Parkinson's disease.

Khunderyakova NV, Pshenichnikova TV, Malkov AE, Bulgin IV, Khmil NV, Medvedeva VP, Glushkova OV, Lunin SM, Parfenyuk SB, Khrenov MO, Mironova GD.

Exp Neurol · 2026-09-26

DOI: 10.1016/j.expneurol.2026.116035PMID: 42800602

Neurotoxicity of PM2.5-Bound Multi-Pollutant Mixtures in Parkinson’s Disease: Exploring the INPP5D/SHIP1-PI3K-AKT Axis via an Integrative Multi-Omics Study

Chen L, Dai C, Wu Z, Lin Y, Lin X, Chen S, Fu M, Wang Y, Ye Q.

Journal of xenobiotics · 2026-09-25

Neurotoxicity of PM_2.5-Bound Multi-Pollutant Mixtures in Parkinson's Disease: Exploring the <i>INPP5D</i>/SHIP1-PI3K-AKT Axis via an Integrative Multi-Omics Study.

Chen L, Dai C, Wu Z, Lin Y, Lin X, Chen S, Fu M, Wang Y, Ye Q.

Journal of xenobiotics · 2026-09-25

DOI: 10.3390/jox16060184PMID: 42931070

Spatial multi-omics reveals disease-associated oligodendrocytes and metabolic dysregulation in male Parkinson's disease mouse models.

Zhu Z, Xu Z, Chen M, Ding L, Feng D, Liang F, Shu H, Su Z, Huang X, Zhu X, Liang X, Huang S, Xu P, Zhang W.

Nature communications · 2026-09-25

DOI: 10.1038/s41467-026-78051-5PMID: 42934224

Quantifying Data Leakage in Multimodal Clinical Augmentation: A Decomposition Framework and a Leakage-Free Evaluation Protocol for Parkinson's Disease Classification

Djemaa MH, Chasseray Y, Thabet R, Jemili F, Lamine E.

· 2026-09-25

DOI: 10.21203/rs.3.rs-10534776/v1

Gait characteristics track biological disease stages in Parkinson’s disease

Pirini C, Alcock L, Kirk C, Lawson RA, Carroll C, Rochester L, Din SD, Yarnall AJ.

· 2026-09-25

DOI: 10.21203/rs.3.rs-10905122/v1

Delayed Feedback Improves Learning in Individuals with Parkinson’s Disease

Sucich K, Cagna CJ, Weber E, Dobryakova E.

· 2026-09-25

DOI: 10.31234/osf.io/dvq2a_v1

Validity Gates Expose Limits of Longitudinal Multimodal Parkinson Disease Prediction

Tirhekar HM, Yadav P, Bajaj C.

· 2026-09-25

DOI: 10.64898/2026.09.23.26363849

Lactoferrin-modified MSC-derived extracellular vesicles facilitate BBB penetration and enhance gastrodin-induced neuroprotection in Parkinson's disease: involvement of mitophagy

Luo Z, Han R, Guo T, Huang H, Su B, Xu J, Zhang W, Li J, Sang Z, Mei Z, Wang K, Zhang Z, An S, Chen H.

International journal of pharmaceutics: X · 2026-09-25